Screening for Down's syndrome: experience in an inner city health district
- 1 December 1996
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 103 (12) , 1205-1211
- https://doi.org/10.1111/j.1471-0528.1996.tb09630.x
Abstract
Objective To review the experience of Down's syndrome screening in an inner city health district.Design In this retrospective study the names of the women were obtained from the Regional Cytogenetic Laboratory and District Down's Syndrome Register. Antenatal notes of the mothers were studied. Maternal age during the affected pregnancy, screening test performed if any, gestational age at booking and at screening, screening test results, and pregnancy outcome were reviewed.Setting An inner city health district.Population Down's syndrome cases diagnosed prenatally and postnatally.Interventions None.Results Antenatal diagnosis of Down's syndrome was made in 15/45 women (33.3%); Edwards' syndrome was diagnosed antenatally in 2/5 women. Screening was not performed in eight women (17.8%) whose infants were affected by Down's Syndrome; it was also not performed in one woman whose baby was affected by Edwards' syndrome due to late presentation to the antenatal clinic or loss of the blood sample. Nineteen women (42.2%) with a Down's syndrome pregnancy and two women with a Edwards' syndrome pregnancy had had a negative screening test. Three women had had a positive screening test but declined amniocentesis. Among those who had a screening test, the overall detection rate of screening was 48.6% (18/37) for Down's syndrome and 50% (2/4) for Edwards' syndrome. The detection rates in different ethnic groups did not show significant difference. Four women chose not to have termination following diagnosis of Down's syndrome, giving a total reduction rate of 21 %.Conclusion Screening programmes for Down's syndrome have not yet resulted in a substantial reduction in the number of affected babies. In addition to trials at developing screening programmes with better detection rates, efforts should be made to improve the provision of the screening service and the quality of antenatal care in general with emphasis on early presentation and optimal understanding of the implications of the tests.Keywords
This publication has 22 references indexed in Scilit:
- Down's syndrome births and pregnancy terminations in 1989 to 1993: preliminary findingsBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programmePrenatal Diagnosis, 1994
- Psychological consequences of screening for Down's syndrome.BMJ, 1993
- The extent of Down's syndrome screening in Britain in 1991The Lancet, 1992
- Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and agePrenatal Diagnosis, 1991
- Factors influencing the uptake of screening for open neural‐tube defects and amniocentesis to test for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein levelBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- ALPHAFETOPROTEIN AND CHORIONIC GONADOTROPIN LEVELS IN RELATION TO DOWN'S SYNDROMEThe Lancet, 1984